Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-213597
Filing Date
2013-05-10
Accepted
2013-05-10 14:34:20
Documents
14
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d534545d10q.htm 10-Q 187118
2 EX-10.AI d534545dex10ai.htm EX-10.AI 73272
3 EX-10.AJ d534545dex10aj.htm EX-10.AJ 79154
4 EX-10.AK d534545dex10ak.htm EX-10.AK 74440
5 EX-31.1 d534545dex311.htm EX-31.1 9907
6 EX-31.2 d534545dex312.htm EX-31.2 8992
7 EX-32.1 d534545dex321.htm EX-32.1 3029
8 EX-32.2 d534545dex322.htm EX-32.2 4023
  Complete submission text file 0001193125-13-213597.txt   1870826

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT appa-20130331.xml EX-101.INS 138638
10 XBRL TAXONOMY EXTENSION SCHEMA appa-20130331.xsd EX-101.SCH 21809
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE appa-20130331_cal.xml EX-101.CAL 24807
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE appa-20130331_def.xml EX-101.DEF 56051
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE appa-20130331_lab.xml EX-101.LAB 123399
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE appa-20130331_pre.xml EX-101.PRE 107282
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
AP PHARMA INC /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 13832755
SIC: 2834 Pharmaceutical Preparations